Sagebrush Inn & Suites Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Host and the Environment in IBD: Scientific Advances Leading to New Therapeutics (A2)

Scientific Organizers: Gary D. Wu, Scott Snapper, Judy H. Cho and Aida Habtezion


January 13—17, 2019

Sagebrush Inn & Suites, Taos, New Mexico, USA


Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc., Janssen R&D: Pharmaceutical Companies of Johnson & Johnson, Takeda Pharmaceutical Company Limited and Theravance Biopharma


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 4, 2018 [details]
Discounted Abstract Deadline: Oct 4, 2018 [details]
Abstract Deadline: Oct 16, 2018 [details]
Discounted Registration Deadline: Nov 13, 2018 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-A2 "Host and the Environment in IBD: Scientific Advances Leading to New Therapeutics" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 4, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 4, 2018 until December 2, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 4, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On November 13, 2018 845.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After November 13, 2018 1045.00 USD
Discounted STUDENT Registration
More details
Before and On November 13, 2018 620.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After November 13, 2018 820.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 4, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is October 16, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 4, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: October 16, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 4, 2018)

Discounted Registration Deadline: November 13, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, January 13 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, January 17 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, January 18 in order to fully experience the meeting.

SUNDAY, JANUARY 13

16:00—20:00
Arrival and Registration

Sagebrush Lobby & Cantina
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Sagebrush Lobby & Cantina

MONDAY, JANUARY 14

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Gary D. Wu, Perelman School of Medicine, University of Pennsylvania, USA

Fiona M. Powrie, University of Oxford, UK
Gut Reactions: Immune Pathways in the Intestine in Health and Disease

09:00—11:15
Clinical Considerations of IBD—What’s the Goal?
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Gary D. Wu, Perelman School of Medicine, University of Pennsylvania, USA

Gilaad Kaplan, University of Calgary, Canada
Clinical Epidemiology: The Rising Incidence of IBD Associated with Industrialization

Coffee Break

Dermot P. B. McGovern, Cedars-Sinai Medical Center, USA
Using Genomics to Explain the Clinical Heterogeneity of IBD

Séverine Vermeire, KU Leuven, Belgium
Current and Future Therapeutics with Companion Diagnostics in IBD

Sarah Valdez, , USA
Short Talk: Patient Advocate: Living with IBD and the Hope for a Better Tomorrow

John Y. Kao, University of Michigan, USA
Short Talk: Congenital Hypothyroidism is a Risk Factor for Inflammatory Bowel Disease

Angela Mo, Georgia Institute of Technology, USA
Short Talk: An Expression Based Risk Score for Prediction of Disease Course in Pediatric Ulcerative Colitis

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
14:30—16:30
Workshop 1: Host Factors in IBD

Chamisa Ballroom 1
* Scott Snapper, Boston Children’s Hospital, USA

* Aida Habtezion, Stanford School of Medicine, USA

June-Yong Lee, New York University School of Medicine, USA
Pathogenic Role of Serum Amyloid A Proteins in Th17-Mediated Chronic Inflammation

Phi Luong, Boston Childrens Hospital, USA
C1ORF106/INAVA-ARNO Complexes Bridge Mucosal Barrier Function with Inflammatory Signaling

Kairui Mao, NIAID, National Institute of Health, USA
Sequential Innate and Adaptive Immunity Establishes Non-Inflammatory Gut Commensalism and Physiologic Host Lipid Metabolism

Vu Ngo, Georgia State University, USA
IL-36 Receptor Signaling Orchestrates IL-23-Mediated Gut Barrier Repair and Defense

Samuel Rubin, Stanford University School of Medicine, USA
Mass Cytometry Reveals Systemic and Local Immune Signatures that Distinguish Inflammatory Bowel Diseases

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
Advances in the Genetics of IBD
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Carl Anderson, Sanger Institute, UK

Judy H. Cho, Icahn School of Medicine at Mount Sinai, USA
Precision IBD and Population Differences in Innate Immunity

Jeffrey Barrett, Genomics plc, UK
Using Human Genetics to Give the Right IBD Patient the Right Drug

Ramnik Xavier, Massachusetts General Hospital and Broad Institute, USA
From IBD-associated Genotypes to Altered Cellular and Organismal Function

Olga Sazonova, 23andMe, USA
Short Talk: Polygenic Modeling Identifies Individuals whose Genetic Risk for IBD is Comparable to Positive Family History

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 1

Chamisa Ballroom 2

TUESDAY, JANUARY 15

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:00
The Mucosal Immune System in IBD—Innate Immunity
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Aida Habtezion, Stanford School of Medicine, USA

Richard S. Blumberg, Brigham and Women's Hospital, USA
nKT Cells and IBD

Clara Abraham, Yale University, USA
Modulation of Innate Immune Responses by IBD-associated Genes

Coffee Break

Gérard Eberl, Institut Pasteur, France
Type 3 Innate Lymphoid Cells Facing Dietary and Microbial Perturbations

Gabriel Nuñez, University of Michigan, USA
Specific NOD2-Microbiota Interactions Drive Crohn's-like Disease

Randy S. Longman, Weill Cornell Medical College, USA
Short Talk: Intestinal Mononuclear Phagocyte-Derived TL1A is a Central Regulator of Group 3 Innate Lymphoid Cells in Inflammatory Bowel Disease

William McAlpine, UT Southwestern, USA
Short Talk: Loss of SMCR8 or WDR41 Results in Immune Dysregulation and Colitis Susceptibility

Naresh Singh Redhu, Boston Children's Hospital, USA
Short Talk: Deletion of STAT1 Ameliorates Early-Onset Colitis in IL10R-deficient Mice

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
The Mucosal Immune System in IBD—Adaptive Immunity
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Scott Snapper, Boston Children’s Hospital, USA

Kenneth Smith, University of Cambridge, UK
T-Cell Exhaustion, Co-Stimulation and Clinical Outcome in Autoimmunity and Infection

Vijay K. Kuchroo, Brigham and Women's Hospital, Harvard Medical School, USA
Induction of Effector and Regulatory T Cells

Aida Habtezion, Stanford School of Medicine, USA
Trafficking and Immune Response in IBD

Wei Yang, University of Alabama at Birmingham, USA
Short Talk: Protein Kinase 2 (CK2) is Required for CD4+ T Cell Function in the Pathogenesis of Colitis

Yu Hui Kang, Boston Children's Hospital, USA
Short Talk: STAT1 Signaling Shields T Cells from NK Cell-Mediated Cytotoxicity to Enable Intestinal Inflammation

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 2

Chamisa Ballroom 2

WEDNESDAY, JANUARY 16

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:00
The Environment in IBD Pathogenesis (Microbiome)
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* June L. Round, University of Utah, USA

Andreas J. Bäumler, University of California, Davis, USA
Healthy Guts Exclude Oxygen

June L. Round, University of Utah, USA
A Role for Fungi in IBD

Coffee Break

Andrew J.S. Macpherson, University of Bern, Switzerland
Microbial Network Disturbances in Relapsing Refractory Crohn’s Disease

David N. Cook, Seres Therapeutics, Inc., USA
A Novel Approach to Treating Active Ulcerative Colitis using Microbial Consortia

Samantha Hsieh, Washington University School of Medicine, USA
Short Talk: Diet Modulates T Cell Immune Responses by Regulating the Expression of a Dominant Antigen from a Gut Symbiont

Eric C. Martens, University of Michigan Medical School, USA
Short Talk: Combined Low Dietary Fiber and Mucus-Degrading Symbiotic Gut Bacteria Cause Lethal Colitis in IL-10 Deficient Mice

Amira Metwaly, Technical University of Munich, Germany
Short Talk: Integrative Multi-Omics Identification of Biomarker Microbial Signatures

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
14:30—16:30
Workshop 2: Environmental Factors in IBD

Chamisa Ballroom 1
* Judy H. Cho, Icahn School of Medicine at Mount Sinai, USA

* Gary D. Wu, Perelman School of Medicine, University of Pennsylvania, USA

Roberta Caruso, University of Michigan, USA
Specific Host-Microbiota Interactions Drive the Development of Crohn’s Disease-Like Colitis in Mice

Benoit Chassaing, Georgia State University, USA
Dietary Emulsifiers Directly Impact Adherent and Invasive E. coli, Promoting Intestinal Inflammation

Uri Gophna, Tel Aviv University, Israel
Prolonged Antibiotic Treatment of Pouchitis Generates Broad Microbiome-Wide Resistance to Fluoroquinolones as well as Collateral Resistance

Nobuhiko Kamada, University of Michigan, USA
Adherent-Invasive Escherichia coli Employs Diet-Derived Amino Acids to Maximize its Fitness in the Inflamed Gut

Serre-Yu Wong, Mount Sinai Hospital, USA
Host Microbe and Intra-Microbiome Interactions Leading to Small Intestinal Inflammation in Nod2-/- Mice

Sungwhan F. Oh, Brigham and Women's Hospital/Harvard Medical School, USA
Structure and Immunoprotective Functions of Gut Symbiotic Glycosphingolipids: Direct Impact of the Host Diet

Hao Tran, Georgia State University, USA
Flagellin-Elicited Adaptive Immunity Suppresses Flagellated Microbiota and Vaccinates against Chronic Inflammatory Diseases

Emilie Viennois, Georgia State University, USA
Fecal miRNAs, Mediators of the Host-Microbiota Interaction, Can Restore Intestinal Health

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
Barrier Function in IBD
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Dirk Haller, Technical University of Munich, Germany

Thaddeus S. Stappenbeck, Washington University School of Medicine, USA
The Intestinal Epithelium in IBD

Lora V. Hooper, University of Texas Southwestern Medical Center, USA
Interactions Among the Microbiota, the Immune System, and the Circadian Clock

Andrew T. Gewirtz, Georgia State University, USA
Gut Microbiota, Diet, and Chronic Inflammation

Pradipta Ghosh, University of California San Diego, USA
Short Talk: Network-Based Approaches to Improve Precision and Prediction in IBD Therapeutics

Jordi M. Lanis, University of Colorado Anschutz Medical Campus, USA
Short Talk: Contributions of Creatine Kinase to Mucosal Immune Responses in Murine Colitis

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 3

Chamisa Ballroom 2

THURSDAY, JANUARY 17

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:00
Translational Opportunities (Bench to Bedside and Back Again)
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Judy H. Cho, Icahn School of Medicine at Mount Sinai, USA

Gary D. Wu, Perelman School of Medicine, University of Pennsylvania, USA
Engineering the Gut Microbiome in IBD

Scott Snapper, Boston Children’s Hospital, USA
Identifying Novel Immune Therapeutics through Studying Rare Diseases

Coffee Break

Gregory C. Gibson, Georgia Institute of Technology, USA
Integrative Genomics in Discriminating IBD Progression

Markus F. Neurath, University Hospital Erlangen, Germany
Bridging the Gap between IBD Pathogenesis and the Development of New Therapeutics

Dominic Boardman, University of British Columbia, Canada
Short Talk: Engineering Flagellin-Specific Regulatory T Cells to Restore Intestinal Homeostasis in IBD

Ting Fu, The Salk Institute, USA
Short Talk: Nutritional Modulation of Intestinal Innate Immunity by BA-FXR Axis

11:00—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—18:45
New Technologies and Collaborations between Industry and Academia
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
* Clara Abraham, Yale University, USA

Speaker to be Announced

Scott Plevy, Janssen, USA
Restoration of Immune and Microbial Homeostasis by a Live Bacterial Therapeutic: Investigations into Mechanisms and Development of VE202

Chas Bountra, University of Oxford, UK
Big Data in Pharma-Academic Collaborations

Elizabeth Wiellette, Draper Laboratory, USA
Short Talk: A High-Throughput Microphysiologic System to Accurately Model Human Colon and Ileum

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/13/2018

Chamisa Ballroom 1
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Chamisa Ballroom 2

FRIDAY, JANUARY 18

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Boehringer Ingelheim Pharmaceuticals, Inc. Janssen R&D: Pharmaceutical Companies of Johnson & Johnson
Takeda Pharmaceutical Company Limited Theravance Biopharma

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 DK118917-01

Funding for this conference was made possible (in part) by 1 R13 DK118917-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional support for this conference from:

Kenneth Rainin Foundation

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676